stockrow
Friday 6 November 2026
Export SDGR’s income statement to Excel — free account
Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
29.96
1.19
+4.14%
Follow SDGR
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 2 | 5 | 4 | 2 | 6 | — | — | — |
P/E ratio |
0.00 | 0.00 | 61.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
1.10 | 1.26 | 5.66 | 2.85 | 7.52 | 23.94 | — | — | — |
P/S ratio |
5.13 | 6.75 | 11.64 | 7.20 | 17.83 | 43.97 | 2.01 | 2.01 | 2.01 |
Altman Z″-Score (non-manufacturers) |
(0.33) | 0.84 | 2.95 | 2.78 | 5.58 | 9.61 | 1.03 | 3.58 | — |
P/FCF ratio |
105.42 | 0.00 | 0.00 | 0.00 | 0.00 | 334.26 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(3.47) | (1.09) | (1.14) | (2.22) | (1.96) | (2.48) | (1.40) | — | — |
P/Operating CF |
(81.60) | (45.06) | (67.68) | (52.25) | (124.57) | 108.96 | (15.27) | (15.27) | (15.27) |
P/B ratio |
3.61 | 3.33 | 4.60 | 2.91 | 4.41 | 7.62 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
3.66 | 3.36 | 4.64 | 2.94 | 4.41 | 7.62 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.56 | 4.98 | 9.47 | 4.68 | 13.63 | 38.02 | 1.00 | 1.00 | 1.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
65.53 | (6.57) | (15.01) | (7.08) | (26.59) | 245.25 | (3.29) | (3.29) | (3.29) |
EV/FCF |
73.12 | (6.28) | (13.67) | (6.63) | (24.14) | 289.02 | (3.07) | (3.07) | (3.07) |
Quick Ratio |
2.68 | 3.25 | 4.17 | 4.83 | 6.80 | 9.27 | 2.49 | 3.78 | 2.59 |
Current Ratio |
2.75 | 3.31 | 4.25 | 4.91 | 6.85 | 9.33 | 2.63 | 3.88 | 2.70 |
Net Debt/EBITDA |
2.50 | 1.81 | 2.73 | 3.20 | 5.34 | 11.23 | 2.46 | 3.35 | 2.10 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.33 | 0.26 | 0.29 | 0.25 | 0.18 | 0.24 | 0.62 | 1.10 | 0.62 |
Operating CF/Net income |
(0.13) | 0.84 | (3.36) | 0.80 | 0.70 | (0.68) | 1.06 | 0.83 | 0.88 |
Capex/Depreciation |
(0.24) | (1.19) | (2.41) | (1.84) | (2.52) | (0.69) | (0.50) | (1.82) | 0.00 |
Interest Coverage |
— | — | — | — | — | — | — | — | (105.97) |
| (26.29%) | (38.58%) | 8.17% | (29.69%) | (17.00%) | (9.22%) | 29.80% | 48.62% | 29.75% | |
| (13.33%) | (23.01%) | 5.46% | (20.65%) | (13.36%) | (5.43%) | (17.81%) | (47.09%) | (19.46%) | |
ROIC |
0.00% | (242.29%) | (138.97%) | 0.00% | 0.00% | 0.00% | (202.87%) | (288.46%) | 0.00% |
Return on Tangible Assets |
(29.54%) | (40.03%) | 8.90% | (33.95%) | (18.46%) | (3.98%) | (30.80%) | (33.19%) | (48.75%) |
Average Days of Receivables |
148.92 | 449.06 | 150.13 | 139.36 | 107.31 | 119.46 | 109.82 | 98.71 | 63.96 |
Research and Development Expense of Revenue |
67.67% | 97.23% | 83.89% | 69.84% | 65.91% | 59.85% | 46.06% | 51.81% | 49.68% |
Selling, General and Administrative Expense of Revenue |
53.30% | 67.26% | 62.94% | 67.13% | 62.47% | 55.22% | 56.58% | 54.60% | 55.86% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
16.80% | 24.05% | 22.08% | 21.90% | 19.21% | 9.76% | 2.56% | 1.97% | 0.00% |
Graham Net Nets |
0.12 | 0.17 | 0.12 | 0.23 | 0.17 | 0.12 | 0.36 | 0.36 | 0.36 |
Graham Number |
0.00 | 0.00 | 9.93 | 0.00 | 0.00 | 0.00 | 38.67 | 0.00 | 0.00 |
Earnings Yield |
(7.94%) | (13.32%) | 1.63% | (11.47%) | (4.05%) | (0.64%) | (14.93%) | (14.93%) | (14.93%) |
Free Cash Flow Yield |
0.95% | (11.75%) | (5.95%) | (9.80%) | (3.17%) | 0.30% | (16.22%) | (16.22%) | (16.22%) |
Revenue per Share |
3.48 | 2.86 | 3.02 | 2.54 | 1.95 | 1.80 | 14.25 | 11.55 | 0.88 |
Operating CF per Share |
0.19 | (2.17) | (1.90) | (1.68) | (1.00) | 0.28 | (4.34) | (4.11) | (0.24) |
Capex per Share |
(0.02) | (0.10) | (0.19) | (0.11) | (0.10) | (0.04) | (0.31) | (0.91) | 0.00 |
Free Cash Flow per Share |
0.17 | (2.27) | (2.09) | (1.79) | (1.10) | 0.24 | (4.65) | (5.02) | (0.24) |
Cash per Share |
5.48 | 5.06 | 6.53 | 6.41 | 8.21 | 10.72 | 14.38 | 14.57 | 0.57 |
Shareholders Equity per Share |
4.96 | 5.80 | 7.64 | 6.29 | 7.89 | 10.40 | 16.36 | 15.62 | 0.58 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.96 | 5.80 | 7.64 | 6.29 | 7.89 | 10.40 | 16.36 | 15.62 | 0.58 |
Free Cash Flow |
12.46 | (164.68) | (150.14) | (127.70) | (77.84) | 14.22 | (27.89) | (28.97) | (15.31) |
Working Capital |
330.13 | 443.25 | 434.12 | 425.19 | 533.85 | 609.77 | 73.52 | 77.69 | 30.24 |
Capital Expenditures |
(1.44) | (7.31) | (13.40) | (8.01) | (7.17) | (2.54) | (1.84) | (5.26) | (3.70) |
Net Current Asset Value |
157.16 | 233.21 | 313.40 | 293.31 | 425.66 | 560.73 | 61.52 | 74.09 | 26.98 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.04 | 0.06 | 0.04 | 0.05 | 0.02 | 0.02 | 0.08 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.31 | 0.25 | 0.24 | 0.31 | 0.28 | 0.71 | 0.58 | 0.36 | 0.30 |
Cash ROIC |
1.63% | (20.87%) | (14.76%) | (14.12%) | (6.85%) | 1.12% | (15.11%) | (16.63%) | (20.89%) |
Accounts Receivable Turnover |
1.42 | 1.21 | 2.74 | 3.30 | 3.63 | 3.54 | 3.91 | 4.80 | 4.01 |
Accounts Payable Turnover |
10.24 | 5.49 | 5.78 | 9.11 | 8.78 | 7.49 | 11.58 | 10.82 | 7.27 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
36.91 | 51.59 | 80.78 | 43.24 | 40.78 | 68.69 | 35.29 | 42.70 | 36.88 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
179.86 | 172.22 | 79.10 | 54.82 | 37.96 | 30.56 | 21.88 | 13.89 | 13.89 |
Average Payables |
11.06 | 13.74 | 13.14 | 8.77 | 8.24 | 5.96 | 3.15 | 2.19 | 2.19 |
Average Assets |
774.69 | 813.09 | 745.77 | 722.54 | 751.38 | 450.77 | 138.00 | 60.37 | 89.38 |
Average Common Equity |
392.75 | 485.00 | 498.23 | 502.50 | 590.55 | 265.35 | (82.44) | (58.46) | (58.46) |
Columns are period end dates · fundamentals updated 4 Nov 2026